Zeiss announces that it has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI). Using an LSM 980 NLO next generation confocal microscope supplied by ZEISS, MPFI will investigate using implanted GRadient INdex (GRIN) lenses in combination with the Airyscan 2 area detector for deep brain functional neuroscience research. Airyscan…
R&D 100 winner of the day: MilliporeSigma Blazar Platform
As the drug manufacturing process evolves, rapid testing will become an essential component in intensified processing and how the industry will detect adventitious agents. MilliporeSigma has developed a first-of-its-kind assay platform that provides highly sensitive viral detection in just days. The innovative Blazar Platform reduces turn-around-time from up to 63 days to ten days, while…
AI-powered microscope could check cancer margins in minutes
A new microscope from researchers at Rice University and the University of Texas MD Anderson Cancer Center can rapidly image large tissue sections, potentially during surgery, to discover on the spot if the cancer was successfully removed. It was created by engineers and applied physicists at Rice and is described in a study recently published…
R&D 100 winner of the day: A Smart-Care Solution for Chronic Wound, iSCare
Chronic wounds have devastating consequences for patients and contribute to billions of dollars in healthcare costs. Diabetic ulcers have the highest growth rate amongst the global population with wounds and require frequent observation to prevent them from becoming chronic. Fifteen percent of diabetic patients will experience at least one diabetic ulcer in a lifetime. Each…
R&D 100 winner of the day: the Optimizer
CCM (Cardiac Contractility Modulation) therapy, delivered by Impulse Dynamics’ the Optimizer, is a breakthrough treatment that can help many people with heart failure feel better and reduce their symptoms. The therapy is designed to improve the heart’s ability to contract by delivering precisely timed pulses of energy directly to the heart. The Optimizer is the…
Thermo Fisher Scientific expands clinical supply chain services in Europe
To meet accelerating demand for robust clinical supply chain services throughout Europe, Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein, Germany. The new sites will bring much-needed clinical supply chain continuity and specialized cold chain and cryogenic expertise across Europe and globally. Today’s…
Research reveals portable digital chest drainage systems could help minimize spread of COVID-19
Pioneering research, which reveals digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems, has been published in the Seminars in Thoracic and Cardiovascular Surgery journal. The research was led by a team of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust – home to one of…
R&D winner of the day: Artificial intelligence early warning heart disease technology
OSTAR Artificial intelligence early warning heart disease technology discovers abnormal heart conditions and diagnoses cardiac disease in advance. Their new AI algorithm uses BPM/ECG transform spectrum diagram to detect the most common and dangerous types of heart disease. The AI technology is able to prevent and warn potential heart disease patients and also track them,…
EUROIMMUN launches CE-marked PCR test to distinguish between COVID-19 and flu
EUROIMMUN, a PerkinElmer Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus type B. It expands the testing portfolio for acute COVID-19 diagnostics by supporting differential diagnostics between SARS-CoV-2 infections and the common flu. It is available in countries accepting…
Thermo Fisher Scientific further expands global footprint for drug product development and commercial manufacturing
Thermo Fisher Scientific today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. “We have continued to invest strategically in capacity, technology and expertise across our global network so we can accelerate innovation and enhance productivity for our…
Extracting cannabinoids at scale: how chromatography is paving the way for pure compounds
Therapeutic use of cannabis is a growing industry increasingly accepted by the medical community and general public — but that growth may be stopped if biopharma companies lack reliable methods to extract and purify potentially useful compounds from the plant. Tadas Laukaitis, production manager at Sanobiotec, has shared his insights on why chromatography could bridge…
R&D 100 winner of the day: WATCHMAN FLX Left Atrial Appendage Closure
Boston Scientific’s WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device consists of access and delivery systems that permit closure device placement in the left atrial appendage (LAA). The device is designed for patients with Non-valvular atrial fibrillation who are eligible for anticoagulation therapy or who have a contraindication to anticoagulation therapy to reduce the risk…
Hydrogel could open new door for glaucoma treatment without drugs or surgery
Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eyedrops and surgery with a twice-a-year injection to control the buildup of pressure in the eye. The researchers envision the injection being done as an office procedure that could be part of regular patient visits. The possible treatment, which…
Thermo Fisher Scientific releases new CE-marked COVID-19, Flu A/B, RSV Combo Kit
Thermo Fisher Scientific announces CE-marking of its TaqPath COVID-19, Flu A/B, RSV Combo Kit for the in vitro diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV) A/B infections. Using the new kit, laboratories can now run a single test for SARS-CoV-2, influenza (flu) A/B, and RSV to detect and differentiate between diseases that share…
A new nanoemulsion eye drop formulation shows promise in treating multiple blinding diseases including complications of retinal detachment and eye trauma
A team led by Mass Eye and Ear researchers has developed an eye drop to effectively deliver drugs to the retina and other tissues located in the back of the eye, a new technology with potential application for the treatment of multiple blinding diseases. According to a report published online today in Nature Scientific Reports,…
Charnwood Lighthouse Lab goes live processing thousands of COVID-19 tests per day using PerkinElmer’s solutions
PerkinElmer, announced today the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in support of the UK Government’s NHS Test and Trace program. The facility, operated by PerkinElmer Genomics, began processing samples today, and with its…
Extraction of largely unexplored bodily fluid could be a new source of biomarkers
By John Toon, Georgia Institute of Technology Using an array of tiny needles that are almost too small to see, researchers have developed a minimally invasive technique for sampling a largely unexplored human bodily fluid that could potentially provide a new source of information for routine clinical monitoring and diagnostic testing. Biochemical information about the…
A hydrogel that could help repair damaged nerves
Injuries to peripheral nerves — tissues that transmit bioelectrical signals from the brain to the rest of the body — often result in chronic pain, neurologic disorders, paralysis or disability. Now, researchers have developed a stretchable conductive hydrogel that could someday be used to repair these types of nerves when there’s damage. They report their…
The Pistoia Alliance launches user experience maturity model for life sciences
Pistoia Alliance has launched a free to use UXLS (User Experience in Life Sciences) maturity model that will help companies understand what a user-centered design culture will look like for them, and their current trajectory. User experience (UX) is coming to the forefront in life sciences as companies undergoing digital transformation have begun to realize…
A-LabInsider launches app to boost biotech businesses
A-LabInsider’s new application lists all the academic life science labs in Europe, filtering through them to make it easier for small and medium biotech companies to discover compatible labs to do business with. The concept was to create a central place for biotech SMEs to find academic labs through the content of available websites and…
What is atomic spectroscopy?
Atomic spectroscopy is the determination of elemental composition by its electromagnetic or mass spectrum. The study of the electromagnetic spectrum of elements is called Optical Atomic Spectroscopy. Electrons exist in energy levels within an atom. These levels have well defined energies and electrons moving between them must absorb or emit energy equal to the difference…
Dartmouth Engineering professor awarded $400K NSF grant to conduct research on Space Station
Dartmouth Engineering Professor Zi Chen has received a $400,000 grant from the National Science Foundation (NSF), in partnership with the Center for the Advancement of Science in Space (CASIS), to lead a three-year research project on the International Space Station (ISS). Chen’s proposal was one of just three selected from institutions across the country as…
University of Oxford ramps up COVID-19 testing capability
The University of Oxford has joined forces with Thermo Fisher Scientific to ramp up the university’s capacity to deliver COVID-19 testing data. The new rapid testing laboratory and jointly developed Thermo Scientific OmnipathTM Combi SARS-CoV-2 IgG ELISA test detects and quantifies antibodies against the coronavirus and increases the University of Oxford’s testing capacity to up…
Shimadzu supports MoCann Testing to become first state-certified medicinal cannabis testing lab in Missouri
Shimadzu Scientific Instruments (SSI) announces business partner MoCann Testing, a division of EKG Labs, is the first laboratory approved to test medicinal cannabis in Missouri. MoCann Testing offers a full suite of testing services for Missouri Marijuana Cultivators and Manufacturers license holders. SSI is an industry leader in providing analytical instruments, solutions and support that…
Phase Genomics and QIAGEN partner to bring Hi-C epigenetics solutions to U.S. market
QIAGEN this week announced a non-exclusive agreement with Phase Genomics to license specific patents to sell its EpiTect Hi-C kits in the United States. Through this agreement, QIAGEN now has access to support chromatin research in the largest research market in the world. Chromatin conformation research, including chromatin conformational analysis (Hi-C), is an emerging and…